Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

RecruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

September 12, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Gestational Hypertension
Interventions
DEVICE

Nokia-Withings BPM Connect Blood Pressure Monitor

At-home blood pressure (BP) measurements will be weekly via a blood pressure cuff (e.g., Nokia-Withings BPM (Beats per Minute) Connect), with measurements being manually entered into the study specific smartphone app.

DEVICE

Smartwatch Devices

Passive continuous collection of digital data (e.g., daily heart rate trends, activity levels, sleep measurements) for exploratory outcomes will occur via Apple Watches and Fitbit Versa 3s, which are synced to a smartphone application.

Trial Locations (1)

10065

RECRUITING

Weill Cornell Medicine, New York

Sponsors
All Listed Sponsors
collaborator

National Academy of Medicine

UNKNOWN

collaborator

Cornell University

OTHER

collaborator

Apple Inc.

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER

NCT06647511 - Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women | Biotech Hunter | Biotech Hunter